A strategy for accelerating the development of preventive AIDS vaccines

[21] Viral load and heterosexual transmission of human immunodeficiency virus type 1 [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (13) : 921 - 929

[22] Intermediate-size trials for the evaluation of HIV vaccine candidates: A workshop summary [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 16 (03): : 195 - 203

[23] HIV incidence and factors contributed to retention in a 12-month follow-up study of injection drug users in Sichuan Province, China [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (04) : 459 - 463

[24] SANDERS EJ, 2006, AIDS VACC 2006 C AMS

[25] Schneider E., 2006, Morbidity and Mortality Weekly Report, V55, P589

[26] SELF S, 2005, AIDS VACC 2005 C MON

[27] Tarwater PM, 2004, AIDS, V18, P2419

[28] Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX®B/E HIV vaccine trial in Bangkok, Thailand [J]. AIDS, 2004, 18 (02) : 295 - 301

[21] Viral load and heterosexual transmission of human immunodeficiency virus type 1 [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (13) : 921 - 929

[22] Intermediate-size trials for the evaluation of HIV vaccine candidates: A workshop summary [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 16 (03): : 195 - 203

[23] HIV incidence and factors contributed to retention in a 12-month follow-up study of injection drug users in Sichuan Province, China [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 39 (04) : 459 - 463

[24] SANDERS EJ, 2006, AIDS VACC 2006 C AMS

[25] Schneider E., 2006, Morbidity and Mortality Weekly Report, V55, P589

[26] SELF S, 2005, AIDS VACC 2005 C MON

[27] Tarwater PM, 2004, AIDS, V18, P2419

[28] Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX®B/E HIV vaccine trial in Bangkok, Thailand [J]. AIDS, 2004, 18 (02) : 295 - 301